Clinical Trials Logo

Cholera Vaccination Reaction clinical trials

View clinical trials related to Cholera Vaccination Reaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05559983 Recruiting - Clinical trials for Cholera Vaccination Reaction

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Start date: December 5, 2022
Phase: Phase 1
Study type: Interventional

This Phase I, first-in-human study is intended to primarily determine the safety of the dose range with or without Aluminum phosphate adjuvant expected to be needed for later clinical studies, to determine the nature of adverse reactions (i.e., safety profile) and to secondly assess the Aluminum phosphate humoral immune responses in non-endemic population to guide future dose selection.